Announcement under Regulation 30 (LODR)-Change in Management 1 Oct - AGM approved reappointment of CEO Nikhil P. Desai, Executive Director Santosh M. Kakade, and appointment of Prof. Vandana B. Patravale.
Source: Bse
Industrials stocks · Small cap · NSE
Aarti Surfactants Limited (ASL), incorporated in 2018 following the demerger of Aarti Industries' Home and Personal Care segment, is a leading manufacturer of speciality surfactants. It serves 100+ customers in 30+ countries across Asia, Europe, Africa, and the Americas, offering 50+ products for home and personal care industries.
SMA20 -5.8% / mo · MACD +
Latest mapped FPI equity flow was not positive. View sector evidence
Adjusted completed-session prices, rebased to 100
Weak fundamentals, management evidence is still limited to a financial-only Trust Lite signal, price trend is neutral, and recent execution is mixed.
Fundamental lens: valuation, quality, growth, balance sheet, and cash flow.
Revenue +26.4% · PAT +206.1% YoY
Price trend and sector-relative-strength timing.
Legacy margin-of-safety estimate; the revised evidence label remains in shadow validation.
Financial-only signal; management claim evidence is not sufficient yet.
Fundamentals, quarterly history, margins, returns and balance-sheet evidence
Rev +26% YoY · PAT +206% YoY · margin expansion · +6% QoQ · operating leverage
| Metric | This quarter | YoY | QoQ |
|---|---|---|---|
| Revenue | ₹272.9 Cr | +26.4% | +6.5% |
| EBITDA | ₹20.3 Cr | +74.5% | +53.6% |
| Operating margin | 7.4% | +205 bps | +229 bps |
| PAT | ₹9 Cr | +206.1% | +114.8% |
| PAT margin | 3.3% | +194 bps | +167 bps |
NDF means not disclosed in the current structured filing feed. It is intentionally not treated as zero.
Updated 20/10/2026
Trend interpretation, Stage 2, relative strength, volume and indicator evidence
Trend is undirectional — long-term uptrend intact. RSI 46.
Mechanical read from the price + indicator series above. Not a recommendation — technical setups can reverse without warning, especially around earnings and macro events.
U-Score 27 · legacy U-Score band OVERVALUED · valuation evidence and comparable companies
Top U-Score contributors and drags from the latest stored fundamentals.
For this sector, IndiaPulse uses a blended lens rather than relying on a single valuation ratio.
This shows the stored score trend when snapshots exist, and also compares the latest stored nightly score with a live recompute from current fundamentals and price.
12 stored score snapshots. Latest stored move: +0 points.
Business-comparable peers in Industrials — ranked by industry, sub-sector, theme-tag overlap, market cap, and U-Score similarity. Green cells mark the best available peer metric in this table.
Growth engines, risks, management commitments and evidence-backed delivery
Aarti Surfactants reported 12% YoY operational revenue growth to INR 65,908.54 lakhs in FY25. However, EBITDA declined 20% YoY to INR 4,959.96 lakhs, with EBITDA margin contracting to 7.53% from 10.56%. PAT fell 32% YoY to INR 1,454.47 lakhs, and diluted EPS decreased 32% to INR 17.19.
Despite revenue growth, significant margin compression and profit decline in FY25 raise concerns about cost management and pricing power. The company's credit rating was reaffirmed, but financial performance metrics like ROCE and ROE have deteriorated, indicating operational challenges.
Latest issuer-disclosed distribution across 2 reported categories.
Company offers 50+ products catering to home and personal care industries.
Export presence in 30+ countries across Asia, Europe, Africa, and the Americas.
Company benefits from rising consumer focus on hygiene, health, and personal care.
Company is positioned for the industry shift towards sustainable and eco-friendly surfactants.
Increasing consumer focus on hygiene, health, and personal care drives demand for company's products.
The industry's shift towards sustainable and eco-friendly surfactants presents a growth opportunity.
Issuer guidance and extracted claims are tracked against later reported outcomes. Treat these as management statements, not IndiaPulse forecasts.
The provided document presents annual financial results for FY24 and FY25, making year-over-year comparison the most relevant basis to assess performance trends.
Increased 12% YoY to INR 65,908.54 lakhs in FY25 (FY24: INR 58,985.74 lakhs).
Declined 20% YoY to INR 4,959.96 lakhs in FY25 (FY24: INR 6,226.00 lakhs).
Contracted to 7.53% in FY25 from 10.56% in FY24.
Decreased 32% YoY to INR 1,454.47 lakhs in FY25 (FY24: INR 2,132.70 lakhs).
Management's vision is to be the Global Partner of Choice for leading FMCG companies in surfactants and specialty products.
Mission is to deliver high-performance, sustainable surfactant solutions that meet evolving customer needs.
Management states commitment to innovation, quality, and environmental responsibility, ensuring safe and effective products.
| Checkpoint | Current evidence | What to verify next |
|---|---|---|
| Operational Revenue Growth | 12% YoY (FY25) | Sustainability of revenue growth and market share gains. |
| EBITDA Margin | 7.53% (FY25) | Stabilization or improvement in margins, indicating better cost control or pricing power. |
| PAT Margin | 2.21% (FY25) | Improvement in overall profitability and efficiency. |
| ROCE | 11.54% (FY25) | Reversal of the declining trend and improved capital efficiency. |
Verification checkpoints are IndiaPulse research interpretation, not investment advice.
Trust asks: does management behaviour match later outcomes? Higher is better, but confidence and evidence depth matter as much as the number.
Limited evidence: Claim history is still being built. It ranks around the 59th percentile of the scored universe and 56th percentile within Industrials. Main check: financial discipline is weak at 30/100.
This is a financial-behaviour screen, not a claim-tested management reliability verdict.
Financial behaviour is scored, but management claims do not yet have enough outcome checks.
overall median 67 · Industrials: 56th pctile, median 68 · Small: 63rd pctile, median 66
9 documents have extracted text, but claim history is not strong enough yet.
0 claims extracted · No contradicted claim yet
Read Trust alongside U-Score, result consistency, and technical trend. A cheap stock with weak Trust needs a larger margin of safety; a high Trust score does not make an expensive stock attractive by itself.
Read low sub-scores as due-diligence warnings, not automatic sell signals.
Trust Lite uses financial behaviour only. Prefer claim-tested Trust when enough concall claims have later outcomes.
Latest exchange and company disclosures found within the past two years.
Source: Bse
Source: Bse
Source: Bse
Source: Bse
Source: Bse
Source: Bse
Source: Bse
Source: Bse
Source: Bse
Source: Bse
Source: Bse
Source: Bse